Status
Conditions
Treatments
About
The diagnosis of cognitive impairment, including dementia and mild cognitive impairment (MCI), is crucial for timely intervention and management. Various screening tools are available for assessing cognitive function, among which the Mini-Mental State Examination (MMSE), the Addenbrooke's Cognitive Examination (ACE), and the Montreal Cognitive Assessment (MoCA) are widely used. However, the recently developed Ain Shams University Cognitive Assessment (ASCA) has shown promise in detecting early cognitive decline. This study aims to assess the performance of ASCA in diagnosing cognitive impairment against DSM5 criteria.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria: older adult participants 60 years old and above who are native Arabic speakers
Exclusion Criteria:
100 participants in 3 patient groups
Loading...
Central trial contact
Doha Rasheedy, Professor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal